Drug Trial Radar · NCT04789330
Norepinephrine vs Phenylephrine During General Anesthesia
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,626
Actual
Start
Jul 1, 2021
Primary completion
Apr 1, 2022
Study completion Apr 1, 2022
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 9, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
50 million patients undergo surgery each year in the United States. Postoperative mortality is considered the third leading cause of death worldwide. Hypotension during surgery have been linked to increased postoperative morbidity and mortality. Episodes of hypotension during surgery are associated with an increased risk of acute kidney injury, stroke, cardiac events and death. Treating or preventing hypotension during general anesthesia and major surgery was found to improve outcomes. At this time, it is unclear what is the best vasopressor to maintain blood pressure during surgery under general anesthesia. With this pilot pragmatic trial, the investigators will explore the impact of norepinephrine (NE) or phenylephrine (PE) on post-operative events in patients undergoing major surgery with general anesthesia and needing vasopressors infusion to maintain their systemic arterial pressure.
Conditions
- Anesthesia
- Surgery
- Hypotension
Interventions
NorepinephrineDrug
Norepinephrine administered during anesthesia
PhenylephrineDrug
Phenylephrine administered during anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Assigned Vasopressor GivenTime frame: Anesthesia time, up to 24 hours
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Ronald Reagan UCLA Medical Center
Los Angeles, California
Zuckerberg San Francisco General Hospital
San Francisco, California
UCSF Medical Center at Mount Zion
San Francisco, California
UCSF Medical Center at Parnassus
San Francisco, California
UCSF Medical Center at Mission Bay
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.